Showing 1 - 6 of 6
The incentives of pharmaceutical companies to innovate and how competition affects these incentives has been topical in recent years: for the general public, as evidenced by a patent race at an unprecedented pace during the ongoing COVID-19 pandemic; and more specifically for competition...
Persistent link: https://www.econbiz.de/10013227948
Health care is one of the most important public policy areas both due to the economic importance of the sector and its impact on individual well-being. Health and hospital services have historically been provided through centralised, highly regulated or non-market means in most OECD countries...
Persistent link: https://www.econbiz.de/10014041494
While there are no universally accepted definitions, “internet traffic prioritization” or, in broader terms, “network neutrality,” are terms generally used to refer to the equal treatment of internet traffic by internet service or network providers (“ISPs”) over wired or wireless...
Persistent link: https://www.econbiz.de/10014042736
Persistent link: https://www.econbiz.de/10013111581
The article introduces experimental economics as a teaching tool and as an analytical instrument in a competition policy context. Based on experimental data from two training sessions in two different competition authorities, the advantages of an experimental approach in conveying an intuitive...
Persistent link: https://www.econbiz.de/10013125858
The UK government progressively privatised the British gas and electricity industry between 1986 and 1996. By 2002 the British energy regulator Ofgem, had first made all customers eligible to choose their supplier and finally lifted price controls for all customer types, driven by the belief...
Persistent link: https://www.econbiz.de/10014146569